Drug Use Survey (DUS) of Triple Therapy (Methycobal (MBL)+ Myonal (MYO)+ Non-steroidal Anti-inflammatory Drags (NSAID)) on the Symptom Relief of Lumbar DDD in China

Clinical trial NCT01299077 · COMPLETED

Trial details

NCT number: NCT01299077
Sponsor: Eisai China Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Lumbar Disc Degenerative Disease

Start date: 2010-06-01
Primary completion: 2010-09-01
Enrollment: 478

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.